Search Results - "Meirena, D."

Refine Results
  1. 1

    Paradoxical effects of two oximes on nitric oxide production by purified NO synthases, in cell culture and in animals by Sjakste, N., Andrianov, V.G., Boucher, J.-L., Shestakova, I., Baumane, L., Dzintare, M., Meirena, D., Kalvinsh, I.

    Published in Nitric oxide (01-11-2007)
    “…We have studied the impact of two novel compounds TO-85 (2,6-di-(α-aziridino-α-hydroxyiminomethyl)pyridine and TO-133 (bis-(diaziridinoglyoximato)copper),…”
    Get full text
    Journal Article
  2. 2

    Increased synthesis of nitric oxide in rat brain cortex due to halogenated volatile anesthetics confirmed by EPR spectroscopy by Baumane, L., Dzintare, M., Zvejniece, L., Meirena, D., Lauberte, L., Sile, V., Kalvinsh, I., Sjakste, N.

    Published in Acta anaesthesiologica Scandinavica (01-04-2002)
    “…Background: Halogenated volatile anesthetics (HVAs) are considered to be inhibitors of nitric oxide synthase (NOS). On other hand, NO mediates the vasodilation…”
    Get full text
    Journal Article
  3. 3
  4. 4

    3-(2,2,2-Trimethylhydrazinium)propionate (THP)--a novel gamma-butyrobetaine hydroxylase inhibitor with cardioprotective properties by Simkhovich, B Z, Shutenko, Z V, Meirena, D V, Khagi, K B, Mezapuķe, R J, Molodchina, T N, Kalviņs, I J, Lukevics, E

    Published in Biochemical pharmacology (15-01-1988)
    “…A protein fraction containing gamma-butyrobetaine hydroxylase (sp.act. 1.54 mU/mg) was isolated from the rat liver by differential precipitation with ammonium…”
    Get more information
    Journal Article
  5. 5
  6. 6
  7. 7

    Effects of γ‐Butyrobetaine and Mildronate on Nitric Oxide Production in Lipopolysaccharide‐Treated Rats by Sjakste, Nikolajs, Baumane, Larisa, Boucher, Jean‐Luc, Dzintare, Maija, Meirena, Dainuvite, Sjakste, Jelizaveta, Lauberte, Lasma, Kalvinsh, Ivars

    Published in Basic & clinical pharmacology & toxicology (01-01-2004)
    “…: Production of nitric oxide was measured in lipopolysaccharide‐treated rats (10 mg/kg, 4 hr) using the electron paramagnetic resonance method. As compared to…”
    Get full text
    Journal Article
  8. 8

    Drastic increase in nitric oxide content in rat brain under halothane anesthesia revealed by EPR method by Sjakste, Nikolajs, Baumane, Larisa, Meirena, Dainuvı̄te, Ļauberte, Lāsma, Dzintare, Maija, Kalviņs̆, Ivars

    Published in Biochemical pharmacology (15-12-1999)
    “…A drastic increase in nitric oxide (NO) content was revealed by the EPR method in rat brain cortex and cerebellum under halothane anesthesia. The NO scavenger…”
    Get full text
    Journal Article
  9. 9

    Cardioprotective effects of N‐hydroxyguanidine PR5 in myocardial ischaemia and reperfusion in rats by Veveris, Maris, Dambrova, Maija, Cirule, Helena, Meirena, Dainuvite, Kalvinsh, Ivars, Wikberg, Jarl E S

    Published in British journal of pharmacology (01-11-1999)
    “…The potential for the N‐hydroxyguanidine compound PR5 (N‐(3,4‐dimethoxy‐2‐chlorobenzylideneamino)‐N′‐hydroxyguanidine) as a cardioprotective agent in heart…”
    Get full text
    Journal Article
  10. 10

    Role of nitric oxide (NO) in the mechanism of anesthetic action by Sjakste, N, Dzintare, M, Baumane, L, Meirena, D, Lauberte, L, Kalvinś, I

    Published in Anesteziologiia i reanimatologiia (01-05-2001)
    “…Published reports on modifications of nitric oxide (NO) synthase (NOS) activity and NO production in the brain during development of anesthesia induced by the…”
    Get more information
    Journal Article
  11. 11

    Effect of doprostone on fatty acid metabolism disturbances in the rat heart caused by adrenergic influences by Simkhovich, B Z, Meĭrena, D V, Khagi, Kh B, Freĭmanis, Ia F

    Published in Farmakologiia i toksikologiia (01-07-1989)
    “…Administration of isoproterenol results in a marked increase (by 4.85 times) of the blood serum concentration of free fatty acids. In the heart there was found…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Comparative study of the antioxidant activity of gamma-butyrobetaine and its natural and synthetic derivatives in vitro by Shutenko, Z I, Aparneva, D A, Meirena, D V, Strump, A V, Venediktova, S G, Ozola, R A, Kal'vinsh, I Y

    “…Experiments in vitro with the use of a rat brain homogenate demonstrated antioxidant activity of methyl ether (3(2,2,2-trimethylhydrazinium) propionate…”
    Get more information
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Prevention of ischemic myocardial damage by reducing the intracellular free carnitine level by Simkhovich, B Z, Vitolinia, R O, Stivrinia, M I, Shutenko, Zh V, Meĭrena, D V

    Published in Kardiologiia (01-07-1987)
    “…3-(2, 2, 2-trimethylhydrazinium) propionate (THP) inhibits gamma-butyrobetaine hydroxylase, which is accompanied by a drop in myocardial free carnitin content…”
    Get more information
    Journal Article
  20. 20

    Potentiation of the antiketogenic effect of exogenous glucose with the help of the new beta-oxidation inhibitor mildronate--3-(2,2,2-trimethylhydrazine)propionate by Shutenko, Zh V, Meĭrena, D V, Kalvin'sh, I Ia, Lukevits, E Ia

    Published in Voprosy meditsinskoi khimii (01-03-1991)
    “…Antiketogenic effect of exogenous glucose (2 g/kg, per os, 1 hr before death) was potentiated after preadministration of mildronate…”
    Get more information
    Journal Article